Pharma companies that used large field forces for multiple divisions, selling the same me-too products to create a resounding Share-of-the-Voice in the market are beginning to Stare-at-the-Diminishing-Returns for investments on traditional sales and marketing strategies, if they can be called strategies at all in the first place. Most pharma companies and professionals like Black & Yellow cabs, continue to hope against hope, that somehow they will be able to continue to hold on to their businesses and jobs till their shares are sold and EMIs are paid. After that, who cares? The answer to pharma and healthcare’s challenges will need a combination of profound domain knowledge and experience combined with digital skills to engage Rx customers meaningfully.

A diverse, summer issue with articles on topics ranging from content marketing to the role of experience in a VUCA world. Also, the latest book for Medical Reps reviewed by Prof. Vivek Hattangadi

Articles by K. Hariram, Vivek Hattangadi, DigiPharmaX, Satya Mahesh, Ajesh Shah and Phanish Chandra

Get an in-depth view into the Draft Pharma Policy - MedicinMan does a deep dive with the President of Karnataka Drug and Pharmaceutical Manufacturers Association

Challenging times lay ahead for the sales departments in the pharma industry. The COVID-19 pandemic will surely not be the first disruption, as recent geopolitical tensions, and economic turmoil show. Agile and adaptive sales enablement is thus a must-have in the coming months and years.

The chemist shop—jammed between a chai stall and a...

A Brief History of Scale and an Unasked Question In...

The recent Mint Lounge analysis captured a striking consumer...

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

In a landmark decision for India’s biotechnology sector, Kiran...

The chemist shop—jammed between a chai stall and a...

A Brief History of Scale and an Unasked Question In...

The recent Mint Lounge analysis captured a striking consumer...

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

In a landmark decision for India’s biotechnology sector, Kiran...

The chemist shop—jammed between a chai stall and a...

A Brief History of Scale and an Unasked Question In...

The recent Mint Lounge analysis captured a striking consumer...

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

In a landmark decision for India’s biotechnology sector, Kiran...

The chemist shop—jammed between a chai stall and a...

A Brief History of Scale and an Unasked Question In...

The recent Mint Lounge analysis captured a striking consumer...

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

In a landmark decision for India’s biotechnology sector, Kiran...